Compare PTEN & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTEN | LIVN |
|---|---|---|
| Founded | 1978 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.3B |
| IPO Year | 1995 | 2015 |
| Metric | PTEN | LIVN |
|---|---|---|
| Price | $11.67 | $78.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | $13.93 | ★ $90.55 |
| AVG Volume (30 Days) | ★ 6.2M | 564.5K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 90.16 | N/A |
| EPS | N/A | ★ 2.33 |
| Revenue | ★ $4,826,624,000.00 | N/A |
| Revenue This Year | $2.15 | $9.65 |
| Revenue Next Year | $7.54 | $7.11 |
| P/E Ratio | ★ N/A | $34.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.24 | $48.82 |
| 52 Week High | $13.39 | $85.76 |
| Indicator | PTEN | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 52.61 |
| Support Level | $11.03 | $77.28 |
| Resistance Level | $11.76 | $82.39 |
| Average True Range (ATR) | 0.45 | 2.09 |
| MACD | 0.07 | 0.43 |
| Stochastic Oscillator | 58.37 | 57.23 |
Patterson-UTI Energy Inc is a Texas based provider of drilling and completion services to oil and natural gas exploration and production companies, offering contract drilling, integrated well completion, directional drilling services, and specialized drill bit solutions. The Company operates through three segments: Drilling Services, Completion Services, and Drilling Products. Drilling Services includes contract and directional drilling, Completion Services generates maximum revenue and includes hydraulic fracturing and related support services, and Drilling Products includes the manufacturing and distribution of drill bits. The Company operates in the United States, Canada, Colombia, and Other Countries, with the majority of revenue coming from the United States.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.